EmploymentStudent ProgramsApply NowContact Us
Jefferson University Hospitals
Photo 1Photo 2Photo 3Pharmacy - Home
Philadelphia Maps and Directions
Employee Benefits
Pharmacy FAQs
Residency Opportunities
About Our Campuses
Jefferson Inpatient Pharmacy
Jefferson Outpatient Pharmacy
 
PGY2 Pharmacy Residency in Infectious Diseases

  Message from Director   FAQs
  Residency Application   Contact Information

Message from the Program Director

Thank you for your interest in the PGY2 Pharmacy Residency in Infectious Diseases at Thomas Jefferson University Hospitals. This residency is designed to develop clinicians with the knowledge and skills necessary to practice as infectious disease specialists. The focus of the residency program is clinical practice, including experiences with inpatient Infectious Diseases consult services, antimicrobial stewardship, and bone marrow transplant services. Residents will develop skills in antimicrobial management and outcomes assessment, education of pharmacy and medical students, and clinical research. The program is extremely flexible and elective experiences can be chosen to complement the individual resident’s career goals.
Throughout the residency year you will have the opportunity to:

  • Provide pharmaceutical care to patients utilizing infectious disease pharmacotherapy.
  • Participate in ongoing clinical initiatives such as aminoglycoside and vancomycin dosing by pharmacy and prolonged beta lactam infusions and help develop new programs.
  • Observe different methods of antimicrobial susceptibility testing.
  • Serve as secretary of the Infectious Disease Pharmacy and Therapeutics Subcommittee.
  • Contribute to the antimicrobial surveillance activities of the department through the antimicrobial stewardship.
  • Conduct a drug use evaluation to determine the appropriateness of antimicrobial therapy.
  • Learn methods of infection control surveillance and reporting.
  • Provide an ACPE-accredited continuing education seminar to pharmacy staff.
  • Participate in learning activities (lectures, preceptorship, etc) for pharmacy and medical students.
  • Design, conduct, and present a research project.
  • Prepare and submit a manuscript for publication in a peer reviewed journal.
  • Attend professional conferences related to infectious diseases.
  • Develop and enhance professional skills (time and stress management, written and verbal communication).

In addition to the clinical component of the program there is a required service component that extends the residency commitment beyond the forty-hour week. Much of the service experience is spent serving as pharmacist-in-charge, performing the administrative functions and overseeing the clinical services provided by the department.

The residency will begin around July 1st. As an accredited PGY2 program, the Residency is listed with the ASHP Residency Matching Program. Selected applicants will be contacted for interviews in late January and throughout February. Qualified candidates must have completed a PGY1 Pharmacy Residency or possess equivalent work experience.

Again, thank you for your interest in our program. Please do not hesitate to contact us with any questions or for further information.

Sincerely,

Claudine El-Beyrouty, PharmD, BCPS
Residency Program Director
Advanced Practice Pharmacist, Infectious Diseases
Claudine.El-Beyrouty@jeffersonhospital.org
215-955-6358

 
       

© 2008 Thomas Jefferson University Hospital
The Web site for Thomas Jefferson University Hospital, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor, is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a healthcare provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University Hospital, Thomas Jefferson University or their staffs. By using this Web site, you accept these terms of use. Please read our privacy statement. Please read our Notice of Privacy Practices.